In a significant transaction demonstrating the strong appeal of healthcare assets, Cell Care in Heatherton has sold for $7.38 million, reflecting a competitive yield of 4.61%.  

The sale was facilitated by Burgess Rawson’s Jamie Perlinger, Natalie Couper, Zomart He and Sam  Mercuri. 

Mr Perlinger said this asset’s unique value and high-performance lease structure attracted intense  investor interest, highlighting the market's confidence in bioscience assets. 

Mr He noted 56% attended bidders were of Asian heritage with a local Chinese buyer ultimately securing the asset. 

“The inflow of Asian capital from offshore to Australia has been significant in the last three months.  

“Asian investors not only take local borrowing cost into consideration, they also take factors such as foreign exchange rate, politics and family immigration into account.  

“They have been the forefront of major commercial property transactions in Australia over the last decade and creating a win-win situation for both local vendors and Asian investors.” 

Cell Care, Australia’s largest cord blood and tissue bank, holds a 17-year net lease until 2032, with a 5- year option. Owned by Nasdaq-listed CooperCompanies, Cell Care benefits from the support of a  global medical device leader.  

Lease terms include tenant responsibility for all outgoings and fixed annual rent increases of 3.5%,  delivering stable income with a current net income of $340,043 per annum plus GST. 

Purpose-built in 2008, the dual-level office and warehouse facility spans 1,108 sqm, featuring customised lab and storage areas for specialised blood preservation. Located just off Warrigal Road, within reach of the bustling Moorabbin Super Centre, this high-traffic site offers convenient access and  robust growth potential as Moorabbin’s population and economic output are forecast to surge  significantly by 2038. 

Mr Perlinger said the sale underscores the demand for quality healthcare assets and well-established  tenants, offering investors long-term stability and growth potential in the evolving bioscience sector

Related Reading

St John of God Health Care industrial investment for sale by Burgess Rawson | The Industrialist